Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease
Yiwen Shi, Qianyi Wang, Yameng Sun, et al.
Journal of Clinical Gastroenterology (2019) Vol. 54, Iss. 4, pp. 378-387
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 8, pp. 739-752
Closed Access | Times Cited: 686
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 235
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Marieke de Vries, Jan Westerink, Karin Kaasjager, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3842-3853
Open Access | Times Cited: 113
Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Feng‐Bin Lu, Kenneth I. Zheng, Rafael S. Rios, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 12, pp. 2041-2050
Open Access | Times Cited: 94
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Mohammad Shafi Kuchay, José Ignacio Martínez‐Montoro, Narendra S. Choudhary, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1346-1346
Open Access | Times Cited: 72
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 36, Iss. 6, pp. 1497-1507
Open Access | Times Cited: 70
NAFLD in normal weight individuals
Johanna K. DiStefano, Glenn S. Gerhard
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study
Takao Miwa, Satoko Tajirika, Nanako Imamura, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 12
Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping
Shahid Habib
World Journal of Gastrointestinal Pathophysiology (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 8
Epidemiology of non-alcoholic fatty liver disease in Asia
Sui‐Weng Wong, Wah‐Kheong Chan
Indian Journal of Gastroenterology (2020) Vol. 39, Iss. 1, pp. 1-8
Closed Access | Times Cited: 52
Nonalcoholic Fatty Liver Disease: A Global Perspective
Wei‐Kei Wong, Wah‐Kheong Chan
Clinical Therapeutics (2021) Vol. 43, Iss. 3, pp. 473-499
Open Access | Times Cited: 47
Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk—A Single-Center Cross-Sectional Study
Georg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
Clinical and Translational Gastroenterology (2021) Vol. 12, Iss. 4, pp. e00326-e00326
Open Access | Times Cited: 40
Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults
Yanan Zhang, Qinqiu Wang, Yi-Shu Chen, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-6
Open Access | Times Cited: 49
Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles
Ziyuan Zou, Vincent Wai‐Sun Wong, Jian‐Gao Fan
Journal of Digestive Diseases (2020) Vol. 21, Iss. 7, pp. 372-384
Closed Access | Times Cited: 43
Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice
Aiting Yang, Xuzhen Yan, Xu Fan, et al.
Hepatology International (2021) Vol. 15, Iss. 5, pp. 1122-1135
Closed Access | Times Cited: 32
Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population‐based study and review of literature
Ashraf Almomani, Prabhat Kumar, Somtochukwu Onwuzo, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 38, Iss. 2, pp. 269-273
Open Access | Times Cited: 25
Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
Plator Memaj, François R. Jornayvaz
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 22
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor Patel, Dhiraj Peddu, Sahil Amin, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 22
Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review
Ran Lu, Ye Liu, Tianpei Hong
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. S1, pp. 13-26
Closed Access | Times Cited: 15
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals
Samuel J. Martínez‐Domínguez, Sandra G. García, Carla J. Gargallo-Puyuelo, et al.
Inflammatory Bowel Diseases (2023)
Open Access | Times Cited: 15
LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up
Chiao‐Lin Hsu, Pin-Chieh Wu, Fu‐Zong Wu, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 4
Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes
Vinod Gupta, Devi Dayal, Anmol Bhatia, et al.
Journal of Pediatric Endocrinology and Metabolism (2025)
Closed Access
The metabolic profiles and body composition of lean metabolic associated fatty liver disease
Yu‐Ming Cheng, Jia‐Horng Kao, Chia‐Chi Wang
Hepatology International (2021) Vol. 15, Iss. 2, pp. 405-412
Closed Access | Times Cited: 31
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity
Partha Pal, Rajan Palui, Sayantan Ray
World Journal of Hepatology (2021) Vol. 13, Iss. 11, pp. 1584-1610
Open Access | Times Cited: 29
NAFLD in type 1 diabetes: overrated or underappreciated?
Jonathan Mertens, Luc F. Van Gaal, Sven Francque, et al.
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top